학술논문
A combination of p53-activating APR-246 and phosphatidylserine-targeting antibody potently inhibits tumor development in hormone-dependent mutant p53-expressing breast cancer xenografts
Document Type
Article
Author
Source
In: Breast Cancer: Targets and Therapy . (Breast Cancer: Targets and Therapy, 22 March 2018, 10:53-67)
Subject
Language
English
ISSN
11791314